The Role of HCPs as Advocates for OTC Brands White Paper
OTC products are often recommended by healthcare providers as a first line of treatment or as an adjunct to Rx therapies. This white paper explores the role of the HCP and why OTC brands should have a more visible, prominent presence in a point of care setting.
Achieving Results Amid a Pandemic White Paper
In this white paper, we look closely at the public's natural reliance on the pharmacy throughout the stay at home orders, and how InStep Health programs continued to deliver lift and ROI for pharma brands even during the most challenging times.
Ways COVID-19 Has Changed the POC
The healthcare landscape has changed in response to COVID-19 and HCPs are adapting their practices in different ways as a result. The InStep Health team of Physician Liaisons surveyed over 250 practices across the US in four different specialties to understand how the COVID-19 epidemic is affecting HCPs and the patients they serve.